Search results for "hyperuricemia"

showing 10 items of 44 documents

Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project

2022

Background and aim: The URRAH (URic acid Right for heArt Health) Study has identified cut-off values of serum uric acid (SUA) predictive of total mortality at 4.7 mg/dl, and cardiovascular (CV) mortality at 5.6 mg/dl. Our aim was to validate these SUA thresholds in people with diabetes. Methods and results: The URRAH subpopulation of people with diabetes was studied. All-cause and CV deaths were evaluated at the end of follow-up. A total of 2570 diabetic subjects were studied. During a median follow-up of 107 months, 744 deaths occurred. In the multivariate Cox regression analyses adjusted for several confounders, subjects with SUA ≥5.6 mg/dl had higher risk of total (HR: 1.23, 95%CI: 1.04-…

Diabetes mellituNutrition and DieteticsSettore MED/09 - Medicina InternaCardiovascular mortalitySerum uric acid Cardiovascular mortality All-cause mortality Diabetes mellitus Hyperuricemia Diagnostic thresholdsEndocrinology Diabetes and MetabolismMedicine (miscellaneous)HyperuricemiaAll-cause mortalityUric AcidDiagnostic thresholdsall-cause mortality; cardiovascular mortality; diabetes mellitus; diagnostic thresholds; hyperuricemia; serum uric acid; humans; risk factors; uric acid; diabetes mellitus; hyperuricemiaDiagnostic thresholdDiabetes mellitusSerum uric acidRisk FactorsAll-cause mortality; Cardiovascular mortality; Diabetes mellitus; Diagnostic thresholds; Hyperuricemia; Serum uric acidHumansCardiology and Cardiovascular Medicine
researchProduct

Factors Influencing Transitions Between Frailty States in Elderly Adults: The Progetto Veneto Anziani Longitudinal Study.

2017

Objectives: To investigate frailty state transitions in a cohort of older Italian adults to identify factors exacerbating or improving frailty conditions. Design: Population-based longitudinal study with mean follow-up of 4.4 years. Setting: Community. Participants: Individuals enrolled in the Progetto Veneto Anziani (Pro.V.A.) (N = 2,925; n = 1,179 male, n = 1,746 female; mean age 74.4 ± 7.3). Measurements: Frailty was identified at baseline and follow-up based on the presence of at least three Fried criteria; prefrailty was defined as the presence of one or two Fried criteria. Anthropometric, socioeconomic, and clinical characteristics were assessed at baseline in a personal interview and…

GerontologyMaleLongitudinal studyFrail ElderlyPopulationVision DisordersfrailtyHyperuricemiaOverweightelderlyNOCohort Studies03 medical and health sciences0302 clinical medicineSex FactorsRisk FactorsOsteoarthritismedicineHumansMedical historyCognitive Dysfunction030212 general & internal medicineLongitudinal StudiesObesityMortalityeducationSocioeconomic statusAgedPolypharmacyeducation.field_of_studybusiness.industrySmokingAge FactorsAnthropometryVitamin D DeficiencySelf EfficacyItalyCardiovascular DiseasesCohortPolypharmacyFemaleGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryJournal of the American Geriatrics Society
researchProduct

Serum leptin is associated with serum uric acid concentrations in humans.

1999

This cross-sectional study aimed to evaluate the relationship between leptin and the cluster of abnormalities often referred to as the metabolic syndrome. The serum leptin concentration, body mass index (BMI), percent body fat, total fat mass (FM), waist and hip circumference, waist to hip ratio (WHR), prevalence of hypertension, and triglyceride (TG), lipoprotein, and uric acid concentration were determined in 86 type 2 diabetic (n = 59) and healthy (n = 27) subjects. Multiple regression analyses showed that the estimates of total body obesity (BMI, percent body fat, and total FM), sex, and serum uric acid concentration are independently associated with the serum leptin concentration. The …

LeptinMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismLipoproteinsBody Mass Indexchemistry.chemical_compoundEndocrinologyWaist–hip ratioSex FactorsInternal medicinemedicineHumansHyperuricemiaObesityTriglyceridesAnalysis of VarianceTriglycerideChemistryLeptinnutritional and metabolic diseasesProteinsSyndromeMiddle Agedmedicine.diseaseObesityUric AcidEndocrinologyCross-Sectional StudiesAdipose TissueDiabetes Mellitus Type 2Case-Control StudiesHypertensionLinear ModelsUric acidBody ConstitutionFemaleMetabolic syndromeBody mass indexMetabolism: clinical and experimental
researchProduct

Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.

2019

Abstract Introduction and objectives Non-alcoholic steatohepatitis (NASH) indication of liver transplant (LT) has increased recently, whereas alcoholic cirrhosis remains a major indication for LT. To characterize NASH-related cases and to compare the post-transplant outcome of these two conditions represents our major objective. Material and methods Patients undergoing LT for NASH between 1997 and 2016 were retrieved. Those transplanted between 1997 and 2006 were compared to an “age and LT date” matched group of patients transplanted for alcoholic cirrhosis (ratio 1:2). Baseline features and medium-term outcome measures were compared. Results Of 1986 LT performed between 1997 and 2016, 40 (…

Liver CirrhosisMaleAlcoholic liver diseaseCirrhosisHepatocellular carcinomamedicine.medical_treatmentSpecialties of internal medicineLiver transplantationGastroenterologyCohort Studies0302 clinical medicinePostoperative ComplicationsLiver Cirrhosis AlcoholicNon-alcoholic Fatty Liver DiseaseCause of DeathHyperuricemiaRenal InsufficiencyCardiovascular risk factorsIncidence (epidemiology)Liver NeoplasmsGeneral MedicineMiddle AgedSurvival RateTreatment OutcomeRC581-951Cardiovascular Diseases030220 oncology & carcinogenesisHepatocellular carcinomaHypertension030211 gastroenterology & hepatologyFemaleAlcoholAdultmedicine.medical_specialtyCarcinoma HepatocellularHyperuricemia03 medical and health sciencesYoung AdultInternal medicinemedicineDiabetes MellitusHumansObesityAgedDyslipidemiasRetrospective StudiesHepatologybusiness.industrynutritional and metabolic diseasesOverweightmedicine.diseasedigestive system diseasesLiver TransplantationSpainSteatohepatitisNeoplasm Recurrence LocalbusinessDyslipidemiaAnnals of hepatology
researchProduct

Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice

2018

Clinically, Chaenomeles sinensis (Thouin) Koehne (C. sinensis) has been used to treat hyperuricemia and gout. However, the exact mechanism of action is still unknown. In the present study, the ethyl acetate fraction of C. sinensis fruit extract (CSF-E) was separated. Potassium oxonate (PO)-induced hyperuricemic mice and normal mice were administered with CSF-E at 60, 120 and 180 mg kg-1, respectively for 7 days. Serum uric acid, creatinine and BUN levels, liver oxidative damage, and serum and hepatic XOD activities were primarily measured using assay kits. The evaluation of its nephroprotective effects was carried out by renal histopathological analysis. Simultaneously, renal protein levels…

Male0301 basic medicineXanthine OxidaseOrganic anion transporter 1PhytochemicalsOrganic Anion TransportersRenal functionHyperuricemiaPharmacologyurologic and male genital diseasesExcretionMice03 medical and health scienceschemistry.chemical_compoundOrganic Anion Transport Protein 1medicineAnimalsHyperuricemiaRosaceaeCreatinineKidneybiologyPlant ExtractsGeneral Medicinemedicine.diseaseUric AcidGoutDisease Models AnimalOxonic Acid030104 developmental biologymedicine.anatomical_structureGene Expression RegulationLiverchemistryCreatinineFruitbiology.proteinUric acidPhytotherapyFood ScienceFood & Function
researchProduct

Hyperuricemia, cardiovascular profile, and comorbidity in older men and women: The Pro.V.A. Study

2017

Hyperuricemia (HU) is growing worldwide and associates with several medical conditions in the elderly. However, data about older people and possible gender differences are sparse. The aim of this study was to compare HU prevalence rates and association with relevant medical disorders in elderly subjects of both sexes. Pro.V.A. is a survey of 3099 individuals aged 65+, focusing on chronic diseases and disability. Uric acid (UA) levels were dichotomized using 6.0 mg/dL (females) and 7.0 mg/dL (males), and multivariate logistic regression models were used to estimate odds ratios (ORs) between HU and single comorbidity. HU prevalence was 21.5% in females and 15.8% in males. HU was associated wi…

MaleAgingmedicine.medical_specialtyPrevalenceComorbidityHyperuricemia030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicineOdds RatioPrevalenceHumansHyperuricemiaLife StyleAged030203 arthritis & rheumatologyAnthropometrybusiness.industryCase-control studyOdds ratioAnthropometrymedicine.diseaseComorbidityUric AcidLogistic ModelsItalyCardiovascular DiseasesCase-Control StudiesPhysical therapyFemalecardiovascular diseases comorbidity elderly gender hypertension hyperuricemiaGeriatrics and GerontologybusinessBody mass index
researchProduct

Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection.

2011

Background Several works observed a link between uric acid serum levels and clinical and histological features of nonalcoholic fatty liver disease. An association between chronic hepatitis C (CHC) and uric acid levels has been poorly investigated. Aims To assess the potential association between uric acid serum levels and both histological features of liver damage and sustained virological response (SVR) in a homogeneous cohort of CHC patients. Methods Consecutive biopsy-proven CHC patients were included. Hyperuricaemia was diagnosed with uric acid serum levels >7 mg/dl in men, and >6 mg/dl in women. Patients underwent therapy with pegylated interferon plus ribavirin. Results Hyperuricaemia…

MaleHCV STEATOSIS HYPERURICEMIAmedicine.medical_specialtyBiopsyRenal functionHepacivirusHyperuricemiaSettore MED/08 - Anatomia PatologicaGastroenterologychemistry.chemical_compoundPegylated interferonInternal medicineNonalcoholic fatty liver diseasemedicineHumansSettore MED/12 - GastroenterologiaHepatologybusiness.industryRibavirinHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasePrognosisUric AcidFatty LiverEndocrinologychemistryUric acidFemaleSteatosisbusinessBody mass indexBiomarkersmedicine.drug
researchProduct

Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly.

2014

Background: Increased serum uric acid has been considered a cardiovascular risk factor but no study has assessed its relation with hospital mortality or length of stay. On the basis of data obtained from a prospective registry, the prevalence of gout/hyperuricemia and its association with these and other clinical parameters was evaluated in an Italian cohort of elderly patients acutely admitted to internal medicine or geriatric wards. Methods: While the prevalence of gout was calculated by counting patients with this diagnosis hyperuricemia was inferred in patients taking allopurinol at hospital admission or discharge, on the assumption that this drug was only prescribed owing to the findin…

MaleKidney DiseaseSettore MED/09 - Medicina InternahyperuricemiaComorbiditieschemistry.chemical_compoundCardiovascular Diseasegout elderlyAllopurinol; Comorbidities; Elderly; Gout; Hyperuricemia; Outcomes; Age Factors; Aged; Aged 80 and over; Allopurinol; Cardiovascular Diseases; Chronic Disease; Comorbidity; Female; Gout; Hospital Mortality; Hospitalization; Humans; Hyperuricemia; Kidney Diseases; Length of Stay; Male; Treatment Outcome; Uric Acid; Internal Medicine; Medicine (all)80 and overMedicineAge FactorHyperuricemiaHospital MortalityOutcomeAged 80 and overOUTCOMESMedicine (all)Age FactorsHospitalizationcomorbidityTreatment OutcomeCardiovascular DiseasesAllopurinol; Comorbidities; Elderly; Gout; Hyperuricemia; OutcomesCohortFemaleKidney DiseasesComorbiditieAllopurinol; Comorbidities; Elderly; Gout; Hyperuricemia; Outcomes; Age Factors; Aged; Aged 80 and over; Allopurinol; Cardiovascular Diseases; Chronic Disease; Comorbidity; Female; Gout; Hospital Mortality; Hospitalization; Humans; Hyperuricemia; Kidney Diseases; Length of Stay; Male; Treatment Outcome; Uric AcidHumanmedicine.drugmusculoskeletal diseasesmedicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesAllopurinolAllopurinol; Comorbidities; Elderly; Gout; Hyperuricemia; Outcomes; Age Factors; Aged; Aged 80 and over; Allopurinol; Cardiovascular Diseases; Chronic Disease; Comorbidity; Female; Gout; Hospital Mortality; Hospitalization; Humans; Hyperuricemia; Kidney Diseases; Length of Stay; Male; Treatment Outcome; Uric Acid; Internal MedicineallopurinolNOgoutGout allopurinol hyperuricemia comorbidities outcomes elderlyInternal medicineInternal MedicineHumansRisk factorIntensive care medicineAdverse effectAgedELDERLYgout allopurinol hyperuricemia comorbidities outcomes elderlybusiness.industrynutritional and metabolic diseasesLength of Staymedicine.diseaseComorbidityGoutUric AcidchemistryChronic DiseaseUric acidbusiness
researchProduct

Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults

2017

Background and Aims In experimental investigations conducted in rats, raising serum uric acid (SUA) levels resulted in the stimulation of intrarenal renin expression. Studies in humans exploring the association of SUA with plasma renin activity (PRA) yielded conflicting results. Moreover, little is known about the relationship of SUA with plasma aldosterone concentration (PAC). The study aimed to assess the relationship between SUA levels, PRA, and PAC and the influence of age, gender, body mass index (BMI), and hyperuricemia on these relationships in subjects with essential hypertension (EH). Methods and Results We enrolled 372 hypertensive patients (mean age 45 ± 12 years, men 67%) with u…

MaleSettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030204 cardiovascular system & hematologyEssential hypertensionKidneyPlasma renin activityRenin-Angiotensin Systemchemistry.chemical_compound0302 clinical medicineRisk FactorsReninNutrition and Dietetic030212 general & internal medicineHyperuricemiaAldosteroneAdiposityNutrition and DieteticsAldosteroneAge FactorsMiddle AgedHypertensionBlood pressureFemaleCardiology and Cardiovascular MedicineAdultArterial hypertensionmedicine.medical_specialtyRenal functionHyperuricemiaEssential hypertension03 medical and health sciencesSex FactorsPlasma renin activityPlasma aldosteroneInternal medicinemedicineHumansSettore MED/14 - NefrologiaCreatinineChi-Square Distributionbusiness.industrymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCross-Sectional StudieschemistryMultivariate AnalysisLinear ModelsUric acidbusinessBody mass indexUric acidBiomarkers
researchProduct

Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study.

2015

Several studies have demonstrated a relationship between increased serum uric acid (SUA) concentrations and the prevalence of metabolic syndrome (MetS) in the oriental population. However, to the best of our knowledge, the association between SUA and MetS has never been investigated in elderly European individuals at high cardiovascular risk. The aim of this study was to conduct a cross-sectional and prospective evaluation of the associations between SUA concentrations and the MetS in elderly individuals at high cardiovascular risk.Men and women (55-80 years of age) from different PREDIMED (Prevención con DIeta MEDiterránea) recruiting centers were studied. Baseline cross-sectional (n = 441…

MaleSíndrome metabòlicamedicine.medical_specialtyCross-sectional studyEndocrinology Diabetes and MetabolismPopulationMedicine (miscellaneous)0939-4753HyperuricemiaBioquímica i biotecnologiaBody Mass IndexAsian PeopleRisk FactorsInternal medicineSurveys and QuestionnairesPrevalenceMedicineHumansHyperuricemiaProspective StudieseducationProspective cohort studyAgedAged 80 and overHypertriglyceridemiaMetabolic SyndromeBioquímica y tecnologíaeducation.field_of_studyNutrition and Dieteticsbusiness.industryHazard ratioCholesterol HDLPREDIMED studyCholesterol LDLMiddle Agedmedicine.diseaseUric AcidBiochemistry and technologyCross-Sectional StudiesLogistic ModelsQuartileCardiovascular DiseasesHypertensionFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessBody mass indexFollow-Up StudiesNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct